1. Home
  2. MRVI vs PCN Comparison

MRVI vs PCN Comparison

Compare MRVI & PCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$7.48

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Pimco Corporate & Income Strategy Fund

PCN

Pimco Corporate & Income Strategy Fund

HOLD

Current Price

$10.77

Market Cap

880.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRVI
PCN
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
880.2M
IPO Year
2020
2001

Fundamental Metrics

Financial Performance
Metric
MRVI
PCN
Price
$7.48
$10.77
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $4.13
N/A
AVG Volume (30 Days)
★ 2.6M
489.5K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 14.29
N/A
EPS
N/A
★ N/A
Revenue
★ $185,743,000.00
N/A
Revenue This Year
$12.54
N/A
Revenue Next Year
$7.87
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.55
$10.56
52 Week High
$9.42
$13.49

Technical Indicators

Market Signals
Indicator
MRVI
PCN
Relative Strength Index (RSI) 55.31 20.88
Support Level $5.54 N/A
Resistance Level $9.42 $12.10
Average True Range (ATR) 0.36 0.15
MACD 0.03 -0.07
Stochastic Oscillator 79.22 18.14

Price Performance

Historical Comparison
MRVI
PCN

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

About PCN Pimco Corporate & Income Strategy Fund

PIMCO Corporate & Income Strategy Fund is a closed-end management investment company. Its objective is to seek high current income with capital appreciation as a secondary objective. It invests in corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, short-term instruments, and others.

Share on Social Networks: